Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Unknown 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 108Gastrointestinal 93Other hematologic neoplasm 90Breast 72Thoracic 65Lymphoid 45Genitourinary 41Gynecologic 36Myeloid 34Head & Neck 25Plasma cell 18Tumor-Agnostic 15Dermatologic 15Sarcoma 14Endocrine 12CNS 8Classical hematology 6Other 5NET 5Other neoplasm 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 13Peripheral Blood Stem Cell Transplantation 9Biopsy 9fludarabine phosphate 8Busulfan 8Whole-Body Irradiation 7Surveys and Questionnaires 6Mycophenolic Acid 6Educational Status 6Early Intervention, Educational 6Carboplatin 6fludarabine 5Tacrolimus 5Paclitaxel 5Methotrexate 5Methods 5Melphalan 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Colposcopy 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4Selenium 4Radiotherapy 4Patient Reported Outcome Measures 4Magnetic Resonance Spectroscopy 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Injections × Other neoplasm × Clear all
NCT05867563 2023-07-10

Clinical Trial Evaluating the Safety of the TQB2103 for Injection

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 1 Unknown
71 enrolled
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡